中华老年医学杂志
中華老年醫學雜誌
중화노년의학잡지
Chinese Journal of Geriatrics
2009年
7期
549-551
,共3页
崔师玉%李茵茵%林海燕%车筱琪%王哲%陈海燕
崔師玉%李茵茵%林海燕%車篠琪%王哲%陳海燕
최사옥%리인인%림해연%차소기%왕철%진해연
前列腺增生%前列腺特异抗原%代谢综合征X
前列腺增生%前列腺特異抗原%代謝綜閤徵X
전렬선증생%전렬선특이항원%대사종합정X
Prostatic hyperplasia%Prostate-specific antigen%Metabolic syndrome X
目的 探讨代谢综合征(metabolic syndrome,MS)与前列腺体积的相关性. 方法 选择年龄36～90岁男性1098人,采用2004年中华医学会糖尿病学分会提出的MS建议诊断标准.分为MS组和对照组.测量血压、身高、体质量,计算体质指数(BMI).生化分析包括血糖、总胆固醇、三酰甘油、低密度脂蛋白胆固醇(LDI-C)、高密度脂蛋白胆固醇(HDL-C)和前列腺特异性抗原(PSA).采用经腹部超声测量前列腺体积. 结果 (1)与对照组比较.MS组的BMI、收缩压、舒张压、空腹血糖、三酰甘油、总胆固醇、前列腺体积和PSA水平较高,但HDL-C水平较低(均P<0.05);(2)MS组前列腺体积较对照组增大,分别为(31.0±11.1)ml和(37.8±21.3)ml,两组差异有统计学意义(P<0.01);(3)前列腺体积与血清PSA水平(r=0.350,P<0.01)、年龄(r=0.429,P<0.01)、BMl(r=0.145,P<0.01)、收缩压(r=0.133,P<0.05)呈正相关,与舒张压(r=0.193,P<0.01)呈负相关. 结论 MS与前列腺体积增大有关.
目的 探討代謝綜閤徵(metabolic syndrome,MS)與前列腺體積的相關性. 方法 選擇年齡36～90歲男性1098人,採用2004年中華醫學會糖尿病學分會提齣的MS建議診斷標準.分為MS組和對照組.測量血壓、身高、體質量,計算體質指數(BMI).生化分析包括血糖、總膽固醇、三酰甘油、低密度脂蛋白膽固醇(LDI-C)、高密度脂蛋白膽固醇(HDL-C)和前列腺特異性抗原(PSA).採用經腹部超聲測量前列腺體積. 結果 (1)與對照組比較.MS組的BMI、收縮壓、舒張壓、空腹血糖、三酰甘油、總膽固醇、前列腺體積和PSA水平較高,但HDL-C水平較低(均P<0.05);(2)MS組前列腺體積較對照組增大,分彆為(31.0±11.1)ml和(37.8±21.3)ml,兩組差異有統計學意義(P<0.01);(3)前列腺體積與血清PSA水平(r=0.350,P<0.01)、年齡(r=0.429,P<0.01)、BMl(r=0.145,P<0.01)、收縮壓(r=0.133,P<0.05)呈正相關,與舒張壓(r=0.193,P<0.01)呈負相關. 結論 MS與前列腺體積增大有關.
목적 탐토대사종합정(metabolic syndrome,MS)여전렬선체적적상관성. 방법 선택년령36～90세남성1098인,채용2004년중화의학회당뇨병학분회제출적MS건의진단표준.분위MS조화대조조.측량혈압、신고、체질량,계산체질지수(BMI).생화분석포괄혈당、총담고순、삼선감유、저밀도지단백담고순(LDI-C)、고밀도지단백담고순(HDL-C)화전렬선특이성항원(PSA).채용경복부초성측량전렬선체적. 결과 (1)여대조조비교.MS조적BMI、수축압、서장압、공복혈당、삼선감유、총담고순、전렬선체적화PSA수평교고,단HDL-C수평교저(균P<0.05);(2)MS조전렬선체적교대조조증대,분별위(31.0±11.1)ml화(37.8±21.3)ml,량조차이유통계학의의(P<0.01);(3)전렬선체적여혈청PSA수평(r=0.350,P<0.01)、년령(r=0.429,P<0.01)、BMl(r=0.145,P<0.01)、수축압(r=0.133,P<0.05)정정상관,여서장압(r=0.193,P<0.01)정부상관. 결론 MS여전렬선체적증대유관.
Objective To explore the relationship between metabolic syndrome (MS) and prostate volume. Methods One thousand and ninety-eight males aged 36-90 years were divided into two groups according to the definition of MS by CDS in 2004 : MS group and control group. The blood
pressure, body weight and height were measured, and the body mass index (BMI) was calculated.
Biochemical assays including fasting plasma glucose, total cholesterol, triglycerides, low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and prostate specific antigen (PSA) were performed. Prostate volume was measured by abdominal ultrasound. Results (1) The BMI, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, serum triglyceride, total cholesterol, prostate volume and PSA level were higher, while HDL-C level was lower in MS group than in control group (all P<0.05). (2)Compared with control group, the prostate volume was enlarged in MS group [(37.8±21.3)ml vs. (31.0±11.1)ml, P<0.01]. (3)The prostate volume was positively correlated with PSA level (r= 0. 350, P< 0. 01), age (r = 0. 429, P<0.01), BMI (r=0.145,P<0.01) and systolic blood pressure (r=0.133, P<0.05), and was negatively correlated with diastolic blood pressure (r= -0. 193,P<0. 01). Conclusions Metabolic syndrome is related to the enlargement of prostate volume.
